By Beth Siemer and Kaleb Rasmussen ( October 10, 2025, 6:22 PM EDT) -- As part of a larger crackdown on direct-to-consumer prescription drug advertising, the U.S. Food and Drug Administration published over 55 warning letters on Sept. 16 to online sellers of compounded versions of the popular GLP-1 medications for Type 2 diabetes and weight loss....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.